Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: There have been few reports of covered self-expandable metallic stent (SEMS) placement for malignant hilar-biliary obstruction (MHBO) because of risk of biliary branch obstruction. We studied feasibility and efficacy of 6-mm-diameter, slim, fully covered SEMS (SFCSEMS) in a relatively large cohort.
Methods: We retrospectively evaluated SFCSEMS in unresectable MHBO from December 2016 to September 2021 in Juntendo University Hospital.
Results: We enrolled consecutive 54 unresectable MHBO (18 bile duct, 11 gallbladder, eight pancreatic, two hepatocellular, and 15 metastatic cancer cases) including Bismuth-type II (n = 11), III (n = 17), and IV (n = 26), and placed two (n = 35) or three (n = 19) SFCSEMS. The technical and clinical success rate was 100% and 92.5%, respectively, with 76.3 min of mean procedure time. Recurrent biliary obstruction (RBO) was observed in 35.2% and the median cumulative time to RBO (TRBO) was 181 days. Other adverse events were 11.1% (four mild-pancreatitis, one segmental-cholangitis, and one cholecystitis). There were no failed cases of stent exchange and second SFCSEMS (n = 6) showed significantly lower RBO (16.7% vs. 81.8%, P = .0364) and longer TRBO (undefined vs 86 days; P = .0617) than plastic stent (n = 11).
Conclusions: Endoscopic placement of SFCSEMS for unresectable MHBO was effective and feasible with low incidence of segmental cholangitis, and exchange strategy of SFCSEMS was promising.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/jhbp.1221 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Clinical utility of suprapapillary plastic stents for lifelong biliary drainage in unresectable malignant hilar biliary obstruction.
Gastrointest Endosc
August 2025
Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine.
Background And Aims: Lifelong maintenance of biliary drainage in unresectable malignant hilar biliary obstruction (MHBO) is becoming increasingly critical, as advancements in antitumor therapy improve patient prognosis. We aimed to evaluate lifelong biliary drainage (LBD) outcomes using suprapapillary plastic stent (SPPS) versus self-expandable metallic stent (SEMS) as the initial stent for unresectable MHBO.
Methods: This retrospective single-center study included 106 consecutive patients who underwent biliary drainage for unresectable MHBO with SPPS or SEMS placement above the papilla via endoscopic retrograde cholangiopancreatography between April 2014 and March 2023.
Prospective evaluation study of a novel endoscopic revision technique after metal stent deployment for hepatic hilar obstruction.
Therap Adv Gastroenterol
July 2025
Second Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan.
Background: Malignant hilar biliary obstruction (MHBO) can be treated by stent deployment under endoscopic retrograde cholangiopancreatography. In case of unresectable MHBO, uncovered self-expandable metal stent (UCSEMS) deployment might be recommended. However, endoscopic revision is challenging.
View Article and Find Full Text PDFIrradiation Stents Versus Conventional Stents for Unresectable Malignant Hilar Biliary Obstruction: A Retrospective Study.
Dig Dis Sci
July 2025
State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers and National Clinical Research Center for Digestive Diseases, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, No.169 Changle West Road, Xi'an, 710032, China.
Background: Implantation of irradiation stents demonstrates superiority over conventional metal stents in terms of stent patency and survival for patients with distal malignant biliary obstruction. Here, we aimed to explore the efficacy and advantages of irradiation stents compared with conventional metal stents in patients with unresectable malignant hilar biliary obstruction (MHBO).
Method: Unresectable MHBO patients treated with irradiation stents (IS group) were prospectively enrolled and followed up, and patients treated with conventional stents (CS group) were retrospectively enrolled by propensity score matching.
Clinical outcomes of endoscopic ultrasound-guided hepaticogastrostomy-based internal drainage for unresectable malignant hilar biliary obstruction: a comprehensive evaluation with malignant distal biliary obstruction.
Therap Adv Gastroenterol
July 2025
Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan.
Background: Endoscopic retrograde cholangiopancreatography (ERCP) may not provide adequate drainage for patients with malignant hilar biliary obstruction (MHBO). Endoscopic ultrasound-guided hepaticogastrostomy (EUS-HGS) is a salvage method for malignant distal biliary obstruction (MDBO); however, its effectiveness for MHBO remains unclear.
Objectives: We aimed to evaluate the short- and long-term outcomes of EUS-HGS for MHBO.
Direct comparison of simultaneous and sequential endoscopic metallic bilateral stenting in malignant hilar biliary obstruction.
World J Gastroenterol
May 2025
Digestive Endoscopy Unit, Estaing University Hospital, Clermont-Ferrand 63000, Auvergne-Rhône-Alpes, France.
Background: Endoscopic bilateral biliary drainage is a first line palliative treatment for unresectable malignant hilar biliary obstruction (MHBO) but remains technically challenging. The emergence of self-expandable metallic stents carried by an ultra-thin (6 Fr or smaller) delivery system now permits simultaneous bilateral stent placement. To date, only a few studies have compared this new method with conventional sequential bilateral stenting.
View Article and Find Full Text PDF